Drugs / Sinsunatovir
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06003829 | Jul → Sep 2023 | — | Pfizer | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sinsunatovir | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06003829 ↗ |
| Route | Oral | “PF-07923568 ORAL SUSPENSION” NCT06003829 ↗ |